Back

JPP · Lens · Effect of Oral Isotretinoin on Anxiety and Depression in Patients with Acne

PDF

Article · Volume 11, Issue 3 · pp. 113–118

Effect of Oral Isotretinoin on Anxiety and Depression in Patients with Acne

Balkrisha Nikam1, Varsha Jamale1, S. Tapdia Ravikumar1

  1. 1Department of Dermatology, Venereology and Leprology, Krishna Institute of Medical Sciences (Deemed-to-be University), Karad, Maharashtra, India.

Abstract

Objective: To study the side effect profile of systemic isotretinoin (ITT) and its association with anxiety and depression in the Indian population.Materials and Methods: In this prospective observational study, 300 patients of either gender, aged >12 years, taking oral ITT were evaluated for severity of acne by the visual analog scale (VAS) and psychiatric side effects with the Hamilton anxiety rating scale (HAM-A) and Montgomery Asberg Depression Rating scale (MADRS) at baseline up till the fourth visit. Software R version 3.6.0. was employed to analyze the data.Results: A significant improvement in VAS score was observed at baseline to final visit (P = 0.001). Significant increase in MADRS score was observed at baseline to final visit (P < 0.05) with mild and moderate depression in four (1.3%) and two patients (0.6%), respectively. On the contrary, a significant decrease in HAM-A score was observed over the visits (P < 0.05). Xerosis-Pruritus (79.7%) and cheilitis (82.7%) were the most common side effects observed. A trend from regular menstrual cycles to irregular menstrual cycles was found with ITT. With respect to lipid profile, a significant difference was observed at baseline values to the final visit (P < 0.05).Conclusion: ITT has proven its efficacy in reducing the severity of acne. Although it showed an improvement in anxiety, a negligible association was found with depression. Hence, ITT can be used safely as its benefits outweigh its side effects.

Keywords: Acne; anxiety; cheilitis; depression; retinoids

The full text of this article is available as a PDF. Open the PDF.